# Effects of S-1 and Capecitabine on Coronary Artery Blood Flow

> **NCT02216149** · PHASE2 · TERMINATED · sponsor: **Heikki Joensuu** · enrollment: 20 (actual)

## Conditions studied

- Esophagus Cancer
- Stomach Cancer
- Small Bowel Cancer
- Colon Cancer
- Rectum Cancer

## Interventions

- **DRUG:** S-1
- **DRUG:** Capecitabine
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT02216149
- **Lead sponsor:** Heikki Joensuu
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2018-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02216149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02216149, "Effects of S-1 and Capecitabine on Coronary Artery Blood Flow". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02216149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*